J&J consumer health arm files for IPO, moves closer to spinoff

Johnson & Johnson filed an initial public offering with the U.S. Securities and Exchange Commission for its consumer health unit, Kenvue, moving closer toward a spinoff, Bloomberg reported Jan. 4.

Advertisement

Kenvue includes Johnson & Johnson brands Tylenol, Listerine, Neutrogena and Nicorette in its portfolio. The financial terms of the transaction were not disclosed; however, proceeds from the sale will go to Johnson & Johnson.

The company had a net income of $1.7 billion for the nine-month period ending Oct. 2. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.